{"id":"NCT03814187","sponsor":"Novartis Pharmaceuticals","briefTitle":"Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C","officialTitle":"An Open-label Extension Trial of the Phase III Lipid-lowering Trials to Assess the Effect of Long Term Dosing of Inclisiran Given as Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-04-16","primaryCompletion":"2023-02-13","completion":"2023-02-13","firstPosted":"2019-01-23","resultsPosted":"2024-03-06","lastUpdate":"2024-03-06"},"enrollment":3275,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["ASCVD","Elevated Cholesterol","Heterozygous Familial Hypercholesterolemia","Homozygous Familial Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"Inclisiran Sodium","otherNames":[]}],"arms":[{"label":"Inclisiran","type":"EXPERIMENTAL"}],"summary":"The purpose of this extension study was to evaluate the efficacy, safety, and tolerability of long-term dosing of Inclisiran. The study was a global multicenter study.","primaryOutcome":{"measure":"Proportion of Subjects Achieving Global Lipid Targets for Their Level of ASCVD Risk","timeFrame":"From ORION-8 Day 1 to the end of study (up to 1080 days)","effectByArm":[{"arm":"Phase III Inclisiran-Inclisiran","deltaMin":78.18,"sd":null},{"arm":"Phase III Placebo-Inclisiran","deltaMin":79.07,"sd":null},{"arm":"ORION-3 Rollover","deltaMin":76.81,"sd":null},{"arm":"Total","deltaMin":78.43,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":238,"countries":["United States","Canada","Czechia","Denmark","Germany","Hungary","Netherlands","Poland","South Africa","Spain","Sweden","Ukraine","United Kingdom"]},"refs":{"pmids":["38753448","33990512"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":464,"n":1512},"commonTop":["COVID-19","Diabetes mellitus inadequate control","Hypertension","Diabetes mellitus","Arthralgia"]}}